These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 9149205)

  • 1. Preliminary report on the use of oral tacrolimus (FK506) in the treatment of complicated proximal small bowel and fistulizing Crohn's disease.
    Sandborn WJ
    Am J Gastroenterol; 1997 May; 92(5):876-9. PubMed ID: 9149205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine.
    Egan LJ; Sandborn WJ; Tremaine WJ
    Am J Gastroenterol; 1998 Mar; 93(3):442-8. PubMed ID: 9517654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
    Fellermann K; Ludwig D; Stahl M; David-Walek T; Stange EF
    Am J Gastroenterol; 1998 Oct; 93(10):1860-6. PubMed ID: 9772045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus for Crohn's disease.
    Ruddock B
    Issues Emerg Health Technol; 2006 Sep; (88):1-4. PubMed ID: 16981314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.
    Baumgart DC; Pintoffl JP; Sturm A; Wiedenmann B; Dignass AU
    Am J Gastroenterol; 2006 May; 101(5):1048-56. PubMed ID: 16573777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical response does not correlate with intestinal or blood cyclosporine concentrations in patients with Crohn's disease treated with high-dose oral cyclosporine.
    Sandborn WJ; Tremaine WJ; Lawson GM
    Am J Gastroenterol; 1996 Jan; 91(1):37-43. PubMed ID: 8561141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review article: Medical therapy for fistulizing Crohn's disease.
    Bressler B; Sands BE
    Aliment Pharmacol Ther; 2006 Nov; 24(9):1283-93. PubMed ID: 17059510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporin treatment of anal and perianal lesions associated with Crohn's disease.
    Cat H; Sophani I; Lemann M; Modiglani R; Solue JC
    Turk J Gastroenterol; 2003 Jun; 14(2):121-7. PubMed ID: 14614639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid closure of Crohn's disease fistulas with continuous intravenous cyclosporin A.
    Hanauer SB; Smith MB
    Am J Gastroenterol; 1993 May; 88(5):646-9. PubMed ID: 8480725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease.
    Ochsenkühn T; Göke B; Sackmann M
    Am J Gastroenterol; 2002 Aug; 97(8):2022-5. PubMed ID: 12190171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy.
    Colombel JF; Loftus EV; Tremaine WJ; Pemberton JH; Wolff BG; Young-Fadok T; Harmsen WS; Schleck CD; Sandborn WJ
    Am J Gastroenterol; 2004 May; 99(5):878-83. PubMed ID: 15128354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral tacrolimus treatment of severe colitis in children.
    Bousvaros A; Kirschner BS; Werlin SL; Parker-Hartigan L; Daum F; Freeman KB; Balint JP; Day AS; Griffiths AM; Zurakowski D; Ferry GD; Leichtner AM
    J Pediatr; 2000 Dec; 137(6):794-9. PubMed ID: 11113835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refractory enterovesical and duodenocolic fistulas in Crohn's disease successfully managed with tacrolimus.
    Fukuda A; Nakase H; Seno H; Nabeshima M; Sawada M; Chiba T
    J Gastroenterol; 2005 Apr; 40(4):433-5. PubMed ID: 15870981
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination therapy with oral tacrolimus (FK506) and azathioprine or 6-mercaptopurine for treatment-refractory Crohn's disease perianal fistulae.
    Lowry PW; Weaver AL; Tremaine WJ; Sandborn WJ
    Inflamm Bowel Dis; 1999 Nov; 5(4):239-45. PubMed ID: 10579116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in apoptosis genes predict response to infliximab therapy in luminal and fistulizing Crohn's disease.
    Hlavaty T; Pierik M; Henckaerts L; Ferrante M; Joossens S; van Schuerbeek N; Noman M; Rutgeerts P; Vermeire S
    Aliment Pharmacol Ther; 2005 Oct; 22(7):613-26. PubMed ID: 16181301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Optimizing treatment of complicated forms of inflammatory bowel disease. Fistulizing Crohn's disease].
    Peñate M; Cruz-Santamaría M; Mendoza JL; Peña AS; Díaz-Rubio M; García-Paredes J
    An Med Interna; 2003 Jan; 20(1):37-45. PubMed ID: 12666309
    [No Abstract]   [Full Text] [Related]  

  • 18. Recombinant human granulocyte-macrophage colony stimulating factor (sargramostim) as an alternative therapy for fistulizing Crohn's disease.
    Magno P; Jiménez CE; Ortiz Z; Torres EA
    P R Health Sci J; 2010 Mar; 29(1):60-5. PubMed ID: 20222336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basic fibroblast growth factor as a response parameter to infliximab in fistulizing Crohn's disease.
    Gao Q; Hogezand RA; Lamers CB; Verspaget HW
    Aliment Pharmacol Ther; 2004 Sep; 20(5):585-92. PubMed ID: 15339330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR of the small bowel with a biphasic oral contrast agent (polyethylene glycol): technical aspects and findings in patients affected by Crohn's disease.
    Laghi A; Paolantonio P; Iafrate F; Borrelli O; Dito L; Tomei E; Cucchiara S; Passariello R
    Radiol Med; 2003; 106(1-2):18-27. PubMed ID: 12951547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.